MJA
MJA InSight
MJA Careers
Editorials

Should we screen for lung cancer in Australia?

Mark Hew, Robert G Stirling and Michael J Abramson
Med J Aust 2013; 199 (2): 82-83.
doi:
10.5694/mja13.10439

Systematic screening reduces mortality, but is it the best way to go?

Mark Hew, MB BS, PhD, FRACP, Associate Professor and Head1
Robert G Stirling, BSc(Hons), MB BCh(Hons), FRACP, Associate Professor and Chair of the Lung Cancer Multi-Disciplinary Meeting1
Michael J Abramson, MB BS, PhD, FAFPHM, Professor of Clinical Epidemiology2
1 Allergy, Asthma and Clinical Immunology Service, The Alfred, Melbourne, VIC.
2 School of Public Health and Preventive Medicine, Monash University, The Alfred Centre, Melbourne, VIC.
Article References: 
Reference Text: 
National Lung Screening Trial Research Team; Aberle DR, Adams AM, Berg CD, et al. Reduced lung-cancer mortality with low-dose computed tomographic screening. N Engl J Med 2011; 365: 395-409.
Reference Order: 
1
PubMed ID: 
21714641
Reference Text: 
National Lung Screening Trial Research Team; Church TR, Black WC, Aberle DR, et al. Results of initial low-dose computed tomographic screening for lung cancer. N Engl J Med 2013; 368: 1980-1991.
Reference Order: 
2
PubMed ID: 
23697514
Reference Text: 
Bach PB, Mirkin JN, Oliver TK, et al. Benefits and harms of CT screening for lung cancer: a systematic review. JAMA 2012; 307: 2418-2429.
Reference Order: 
3
PubMed ID: 
22610500
Reference Text: 
Australian Institute of Health and Welfare. National Bowel Cancer Screening Program monitoring report: phase 2, July 2008–June 2011. Canberra: AIHW, 2012. (AIHW Cat. No. CAN 61; Cancer Series No. 65.) http://www.aihw.gov.au/publication-detail/?id=10737421408 (accessed Jun 2013).
Reference Order: 
4
Reference Text: 
Marshall HM, Bowman RV, Crossin J, et al. Queensland Lung Cancer Screening Study: rationale, design and methods. Intern Med J 2013; 43: 174-182.
Reference Order: 
5
PubMed ID: 
22471951
Reference Text: 
Manser R, Dalton A, Carter R, et al. Cost-effectiveness analysis of screening for lung cancer with low dose spiral CT (computed tomography) in the Australian setting. Lung Cancer 2005; 48: 171-185.
Reference Order: 
6
PubMed ID: 
15829317
Reference Text: 
Liu PH, Wang JD, Keating NL. Expected years of life lost for six potentially preventable cancers in the United States. Prev Med 2013; 56: 309-313.
Reference Order: 
7
PubMed ID: 
23428566
Reference Text: 
Pignone MP, Flitcroft KL, Howard K, et al. Costs and cost-effectiveness of full implementation of a biennial faecal occult blood test screening program for bowel cancer in Australia. Med J Aust 2011; 194: 180-185.
Reference Order: 
8
Reference Text: 
Lew JB, Howard K, Gertig D, et al. Expenditure and resource utilisation for cervical screening in Australia. BMC Health Serv Res 2012; 12: 446.
Reference Order: 
9
PubMed ID: 
23216968
Reference Text: 
Shearer J, Shanahan M. Cost effectiveness analysis of smoking cessation interventions. Aust N Z J Public Health 2006; 30: 428-434.
Reference Order: 
10
PubMed ID: 
17073223
Reference Text: 
Jha P, Ramasundarahettige C, Landsman V, et al. 21st-century hazards of smoking and benefits of cessation in the United States. N Engl J Med 2013; 368: 341-350.
Reference Order: 
11
PubMed ID: 
23343063
Reference Text: 
Australian Institute of Health and Welfare and Cancer Australia. Lung cancer in Australia: an overview. Canberra: AIHW, 2011. (AIHW Cat. No. CAN 58; Cancer Series No. 64.) http://www.aihw.gov.au/publication-detail/?id=10737420419 (accessed Jun 2013).
Reference Order: 
12

The full contents of this page are only available to subscribers.